Lipid peroxidation and thymidine phosphorylase expression in prostate carcinoma
Автор: Tandon R., Rath U.S., Pande Deepti, Negi Reena, Karki Kanchan, Khanna Hari D.
Журнал: Журнал стресс-физиологии и биохимии @jspb
Статья в выпуске: 3 т.8, 2012 года.
Бесплатный доступ
Aim: To understand the association between markers of oxidative stress and angiogenesis in relation to disease progression, clinical stage and cytological grade in patho-physiology of prostate carcinoma. Patients and Methods: Case control study comprised of 50 prostate carcinoma patients along with 20 age and sex-matched healthy subjects as controls. Levels of malondialdehyde were measured to study the oxidative stress status in the study subjects. Angiogenesis was evaluated by studying the activity of Thymidine Phosphorylase/Platelet derived endothelial cell growth factor. Results: The levels of markers of oxidative stress along with the activity of thymidine phosphorylase were found to be significantly higher in the study subjects in comparison to healthy controls. The results indicate oxidative stress and angiogenesis activity increase progressively with the increase in staging and progression of disease. Conclusion: Oxidative stress and expression of angiogenesis activity points clearly that with the progression of oxidative stress there is a simultaneous progression of angiogenesis in relation to disease progression, clinical stage and cytological grade in the pathophysiology of prostate carcinoma.
Lipid peroxidation, thymidine phosphorylase activity, prostate carcinoma
Короткий адрес: https://sciup.org/14323653
IDR: 14323653
Список литературы Lipid peroxidation and thymidine phosphorylase expression in prostate carcinoma
- Brown, N.S and Bicknell, R. (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J., 334, 1 -8.
- Brown, N.S., Jones, A., Fujiyama, C., Harris, A.L. and Bicknell, R. (2000) Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res., 60, 6298 -6302.
- Burge, J.A and Aust, S.D. (1978) Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310.
- Fox, S.B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K.C. and Harris, A,L.(1995)Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol., 176, 183 -190.
- Griffiths, L. and Statford I.J. (1997) Platelet-derived endothelial growth factor/thymidine phosphorylase in tumour growth and response to therapy. Br J Cancer., 76, 689 -693.
- Janero, D.R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med., 9, 515-540.
- Koukourakis, M.I., Giatromanolaki, A., Kakolyris, S., O'Byrne, K.J., Apostolikas, N., Skarlatos, J., Gatter, K. C., and Harris, A.L. (1998) Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer, 77, 1696-1703.
- Kuroki, M., Voest, E.E., Amano, S., Beerepoot, L.V., Takashima, S., Tolentino, M., Kim, R.Y., Rohan, R.M., Colby, K.A., Yeo, K.T., and Adamis, A.P. (1996) Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest.,98(7), 1667-1675.
- Moghaddam, A., Zhang, H.T., Fan, T.P., Hu, D.E, Lees, V.C., Turley, H., Fox, S.B., Gatter, K.C., Harris, A.L. and Bicknell R. (1995) Thymidine phosphorylase isangiogenic and promotes tumor growth. Proc Natl Acad Sci USA., 92, 998-1002.
- Moghaddam, A., Choudhuri, R. and Bicknell, R.(1997) Thymidine phosphorylase/platelet-derived endothelial cell growth factor: an angiogenic enzyme. In Tumour Angiogenesis, Bicknell R, Lewis CE, Ferrara N (ed). Oxford University Press. Oxford, UK, pp 251 -260.
- Moul, J.W., Anderson, J., Penson, D.F Klotz, L.H., Soloway, M.S., Schulman, C.C. (2003) Early prostate cancer: prevention, treatment modalities, and quality of life issues. Eur Urol., 44 (3), 283-293.
- Randolph, T.L. Amin, M.B., Ro, J.Y., Ayala, A.G. (1997) Histologic variants of Adenocarcinoma and other carcinoma of the prostate: pathologic criteria and clinical significance. Modern Pathology., 10 (6), 6612-6629.
- Sugamoto, T., Tanji, N., Nishio, S. and Yokoyama, M. (1999). Expression of platelet-derived endothelial cell growth factor in prostatic adenocarcinoma. Oncol Rep., 6, 519-522.
- Weidner, N., Carroll, P.R., Flax, J., Blumenfeld, W. and Folkman, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol., 143, 401-409.
